Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis.
暂无分享,去创建一个
M. Dimopoulos | B. Djulbegovic | T. Facon | M. Mateos | S. Usmani | A. Grimshaw | L. Costa | S. Giri | S. Bal | K. Godby | P. Kharel